Therapeutic drug monitoring
Important Communication regarding COVID-19
As you are aware, the current outbreak of a novel coronavirus (COVID-19) has resulted in national and international changes to the delivery of services and processes.
The Therapeutic Drug Monitoring Unit in Epilepsy Society currently remains open to receive your anti-epileptic drug test referrals, however, there is a required change to turnaround times as a result of reduced capacity in the laboratory operations.
The turnaround time for your referrals will be set at one week [5 working days] from the receipt of the sample with immediate effect and until further notice.
Thank you for your cooperation at this very challenging time and we will contact you in due course when we have a further update.
Dr Karin Kipper
Head of Therapeutic Drug Monitoring Unit
The uses and benefits of drug monitoring
Philip Patsalos presents the uses and benefits of drug monitoring at the healthcare professionals conference.
In this section you will find information about our Therapeutic Drug Monitoring Unit (TDM Unit) at our Chalfont Centre.
Information on what therapeutic drug monitoring is and how it can be accessed.
Information about our Therapeutic Drug Monitoring Unit (TDM Unit) at our Chalfont Centre.
When should drug concentrations be monitored?
Information on samples we use as part of our Therapeutic Drug Monitoring Unit (TDM Unit).
Information on how to use the Therapeutic Drug Monitoring Unit (TDM Unit) service.
List of contacts for our Therapeutic Drug Monitoring Unit (TDM Unit) at our Chalfont Centre.